• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Moderna COVID-19 vaccine patent dispute headed to court, U.S. NIH head says

Mary Wilson

Well-known member
November 10, 20215:31 PM CST
Last Updated 5 hours ago

By Julie Steenhuysen

CHICAGO, Nov 10 (Reuters) - U.S. National Institutes of Health scientists played "a major role" in developing Moderna Inc's (MRNA.O)COVID-19 vaccine and the agency intends to defend its claim as co-owner of patents on the shot, NIH Director Dr. Francis Collins told Reuters on Wednesday.

In a story first reported by the New York Times on Tuesday, Moderna excluded three NIH scientists as co-inventors of a central patent for the company's multibillion-dollar COVID-19 vaccine in its application filed in July.

"I think Moderna has made a serious mistake here in not providing the kind of co-inventorship credit to people who played a major role in the development of the vaccine that they're now making a fair amount of money off of," Collins said in an interview ...

... Moderna expects 2021 sales of $15 billion to $18 billion from the COVID-19 vaccine - its first and only commercial product - and up to $22 billion next year.

https://www.reuters.com/business/he...ute-headed-court-us-nih-head-says-2021-11-10/
 
Back
Top Bottom